Leadership changes
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes, November 2026
287
Appointments
163
Departures
21
Browse by role
Get new CFO appointments the day the filing lands.
Browse by month
Filters
3,399 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Oct 9, 2026 | Hepion Pharmaceuticals, Inc. | Sireesh Appajosyula, PharmD | Chief Executive OfficerCEO | Appointed | Oct 9, 2026 | SEC 8-K |
| Oct 9, 2026 | HUBSPOT INC | Erika Fisher | Chief Legal Officer and Corporate SecretaryCLO | Departed | Nov 6, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | Dirk Thye, M.D. | Chief Executive OfficerCEO | Departed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | Brendan Hannah | Chief Operating OfficerCOO | Departed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | Brigette Roberts, M.D. | Chief Executive OfficerCEO | Appointed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | John Militello, CPA | Chief Financial OfficerCFO | Appointed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | Keith Fandrick | Chief Operating OfficerCOO | Appointed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | June Bray | directordirector | Departed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | David Lamond | directordirector | Departed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | Christopher Senner | directordirector | Departed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | Catherine M. Bonuccelli | Class I director and as a member of the Audit Committee and Compensation CommitteeClass I director and as a member of the Audit Committee and Compensation Committee | Appointed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | Leone Patterson | Class III director and as chair of the Audit Committee and as chair of the Compensation CommitteeClass III director and as chair of the Audit Committee and as chair of the Compensation Committee | Appointed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | James Valentine | Class I director and as a member of the Audit Committee and as chair of the Nominating and Corporate Governance CommitteeClass I director and as a member of the Audit Committee and as chair of the Nominating and Corporate Governance Committee | Appointed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | Drayton Wise | Class II director and as a member of the Nominating and Corporate Governance CommitteeClass II director and as a member of the Nominating and Corporate Governance Committee | Appointed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | MARZETTI CO | Tanya Berman | President of Retail Division of T. Marzetti CompanyPresident | Departed | Oct 6, 2026 | SEC 8-K |
| Oct 9, 2026 | MITEK SYSTEMS INC | Michael E. Diamond | Senior Vice President of Sales, Check VerificationSenior Vice President of Sales, Check Verification | Departed | Dec 8, 2026 | SEC 8-K |
| Oct 9, 2026 | MSG Rangers Corp. | Joseph M. Cohen | directordirector | Appointed | Oct 9, 2026 | SEC 8-K |
| Oct 9, 2026 | MYRIAD GENETICS INC | Brian Donnelly | Chief Commercial OfficerChief Commercial Officer | Departed | Sep 16, 2026 | SEC 8-K |
| Oct 9, 2026 | NextBoat Inc. | Chad Corbin | Chief Financial OfficerCFO | Departed | n/a | SEC 8-K |
| Oct 9, 2026 | Phoenix Education Partners, Inc. | Michael Cochran | interim Chief Financial OfficerCFO | Appointed | Oct 10, 2026 | SEC 8-K |
- Hepion Pharmaceuticals, Inc.Appointed
Sireesh Appajosyula, PharmD CEO
Filed Oct 9, 2026Effective Oct 9, 2026SEC 8-K
- HUBSPOT INCDeparted
Erika Fisher CLO
Filed Oct 9, 2026Effective Nov 6, 2026SEC 8-K
- IRulya Therapeutics Inc.Departed
Dirk Thye, M.D. CEO
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Departed
Brendan Hannah COO
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Appointed
Brigette Roberts, M.D. CEO
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Appointed
John Militello, CPA CFO
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Appointed
Keith Fandrick COO
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Departed
June Bray director
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Departed
David Lamond director
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Departed
Christopher Senner director
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Appointed
Catherine M. Bonuccelli Class I director and as a member of the Audit Committee and Compensation Committee
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Appointed
Leone Patterson Class III director and as chair of the Audit Committee and as chair of the Compensation Committee
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Appointed
James Valentine Class I director and as a member of the Audit Committee and as chair of the Nominating and Corporate Governance Committee
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Appointed
Drayton Wise Class II director and as a member of the Nominating and Corporate Governance Committee
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- MARZETTI CODeparted
Tanya Berman President
Filed Oct 9, 2026Effective Oct 6, 2026SEC 8-K
- MITEK SYSTEMS INCDeparted
Michael E. Diamond Senior Vice President of Sales, Check Verification
Filed Oct 9, 2026Effective Dec 8, 2026SEC 8-K
- MSG Rangers Corp.Appointed
Joseph M. Cohen director
Filed Oct 9, 2026Effective Oct 9, 2026SEC 8-K
- MYRIAD GENETICS INCDeparted
Brian Donnelly Chief Commercial Officer
Filed Oct 9, 2026Effective Sep 16, 2026SEC 8-K
- NextBoat Inc.Departed
Chad Corbin CFO
Filed Oct 9, 2026SEC 8-K
- Phoenix Education Partners, Inc.Appointed
Michael Cochran CFO
Filed Oct 9, 2026Effective Oct 10, 2026SEC 8-K